Company intelligence / Profile preview

Maximus

Santa Monica, California, United Statesmaximus.com ↗

Ownership: Public · MMS
Development stage: Commercial

Overview

Maximus offers commercial telehealth services focused on men's hormone optimization. Their programs are physician-supervised and include at-home diagnostics with prescription therapies. They claim clinical backing for their protocols but do not conduct traditional drug development or clinical trials as a biotech/pharma company would; rather they use approved drugs in new care models.

Therapeutic areas: EndocrinologyMen's Health
Modalities: Small moleculeHormone therapySupplement/nutraceuticals
Industry: Non-Academic Healthcare

Partnerships

Not specified; works with licensed physicians including academic urologists/endocrinologists as advisors/co-developers of protocols.

Financials

Market cap: $3B
Total revenue: $1.3B
Enterprise value: $4.6B

Beyond the preview

Go deeper on Maximus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Maximus.

Explore the full profile